Up-regulation of CTGF mRNA and protein expressions has been confirmed in high glucose-induced mesangial cells and podocytes [7,8] in both diabetic nephropathy animal models [9,10], and type 1 and type 2 diabetic patients [11,12]. This evidence concerns the gene CCN2 and diabetic kidney disease.